VTP-1000 in celiac disease

Overview

About this study

The purpose of this study is to evaluate the safety and tolerability of single and multiple doses of VTP-1000 to define a dose and schedule for further investigation.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Diagnosis of celiac disease as confirmed by positive serology and intestinal histology
  • Presence of Human Leukocyte Antigen (HLA)-DQ2.5 genotype
  • Participants who are on a well controlled gluten restricted diet
  • Negative or weak positive anti-tissue transglutaminase (tTG) IgA antibodies and negative or weak positive anti-deamidated gliadin peptide IgG (anti-DGP)-IgA/IgA antibodies
  • Non-pregnant or breast feeding females
  • No other clinical significant findings at screening

Exclusion Criteria:

  • Refractory celiac disease
  • Selective IgA deficiency
  • Positive for HLA-DQ8
  • Known wheat allergy or that is Type I hypersensitivity
  • Active inflammatory bowel disease or other condition with symptoms that will be similar to celiac disease

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 8/09/2024. Questions regarding updates should be directed to the study team contact.

 

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Adam Bledsoe, M.D.

Contact us for the latest status

Contact information:

Chadrick Hinson

(507) 266-0237

Hinson.Chadrick@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20580116

Mayo Clinic Footer